Holen Sie sich die Stockscreener-App
0.8968
4.30%
0.037
Schlusskurs vom Vortag:
$0.8598
Offen:
$0.861
24-Stunden-Volumen:
290.93K
Relative Volume:
0.15
Marktkapitalisierung:
$11.60M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.70M
KGV:
-0.8153
EPS:
-1.1
Netto-Cashflow:
$-8.57M
1W Leistung:
-3.12%
1M Leistung:
-28.26%
6M Leistung:
-51.26%
1J Leistung:
-71.35%
1-Tages-Spanne:
$0.84
$0.899
1-Wochen-Bereich:
$0.84
$0.92
52-Wochen-Spanne:
$0.8099
$5.95
Marker Therapeutics Inc Stock (MRKR) Company Profile
Firmenname
Marker Therapeutics Inc
Sektor
Branche
Telefon
(713) 400-6400
Adresse
2450 HOLCOMBE BLVD, HOUSTON, TX
Vergleichen Sie MRKR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRKR
Marker Therapeutics Inc
|
0.8968 | 11.12M | 0 | -9.70M | -8.57M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Marker Therapeutics Inc Stock (MRKR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-03-25 | Eingeleitet | Piper Sandler | Overweight |
| 2021-03-19 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-05-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-05-30 | Eingeleitet | ROTH Capital | Buy |
| 2019-03-01 | Eingeleitet | Janney | Buy |
| 2018-12-03 | Hochstufung | Piper Jaffray | Neutral → Overweight |
Alle ansehen
Marker Therapeutics Inc Aktie (MRKR) Neueste Nachrichten
Marker Therapeutics Inc. stock momentum explainedProduct Launch & Real-Time Volume Analysis Alerts - Newser
What’s the outlook for Marker Therapeutics Inc.’s sectorFed Meeting & Free Weekly Watchlist of Top Performers - خودرو بانک
Can Marker Therapeutics Inc. be recession proof2025 Year in Review & Safe Entry Momentum Stock Tips - خودرو بانک
News impact scoring models applied to Marker Therapeutics Inc.July 2025 Closing Moves & Safe Entry Zone Tips - Newser
Will Marker Therapeutics Inc. stock hit new highs in YEARQuarterly Market Summary & Daily Market Momentum Tracking - خودرو بانک
Is Marker Therapeutics Inc. in Accumulation Phase Now2025 Top Gainers & Technical Analysis for Trade Confirmation - beatles.ru
Can Marker Therapeutics Inc. deliver consistent dividendsWeekly Gains Report & Reliable Price Breakout Signals - خودرو بانک
Marker Therapeutics (MRKR) Falls 20.6% After Positive Clinical Study - MSN
Is Marker Therapeutics Inc. in a long term uptrend2025 Market Trends & Real-Time Buy Signal Notifications - خودرو بانک
Will Marker Therapeutics Inc. benefit from rate cutsQuarterly Earnings Summary & AI Driven Price Predictions - خودرو بانک
Marker Therapeutics shares fall 2.54% premarket after Vivoryon Therapeutics reports H1 2025 financial results. - AInvest
What technical models suggest about Marker Therapeutics Inc.’s comebackMarket Activity Summary & Real-Time Volume Analysis Alerts - Newser
Smart tools for monitoring Marker Therapeutics Inc.’s price actionJuly 2025 Momentum & Safe Investment Capital Preservation Plans - Newser
Does Marker Therapeutics Inc. meet Warren Buffett’s criteriaJuly 2025 Earnings & Technical Confirmation Trade Alerts - خودرو بانک
Intraday pattern recognizer results for Marker Therapeutics Inc.Layoff News & Verified Momentum Stock Alerts - Newser
Can Marker Therapeutics Inc. Overcome Bearish SentimentMarket Trend Report & Weekly Chart Analysis and Trade Guides - beatles.ru
Will Marker Therapeutics Inc. benefit from macro trendsJuly 2025 Trade Ideas & Fast Gaining Stock Reports - Newser
How to build a custom watchlist for Marker Therapeutics Inc.2025 Risk Factors & AI Forecasted Entry and Exit Points - Newser
Is Marker Therapeutics Inc. impacted by rising ratesMarket Activity Report & Growth Focused Investment Plans - خودرو بانک
What are the potential risks and opportunities that could influence MRKR's future stock performance - AInvest
Can you recover from losses in Marker Therapeutics Inc.Portfolio Risk Summary & Safe Entry Trade Signal Reports - Newser
Published on: 2025-08-31 19:55:53 - Newser
How to build a dashboard for Marker Therapeutics Inc. stockTake Profit & Intraday High Probability Setup Alerts - Newser
Is it time to cut losses on Marker Therapeutics Inc.Market Trend Review & Daily Stock Momentum Reports - Newser
Should you hold or exit Marker Therapeutics Inc. nowTrade Analysis Report & Daily Volume Surge Signals - Newser
Analyzing Marker Therapeutics Inc. with risk reward ratio charts2025 Sector Review & Growth Oriented Trade Recommendations - Newser
Marker Therapeutics Inc.’s volatility index tracking explainedJuly 2025 News Drivers & Safe Swing Trade Setup Alerts - Newser
Using economic indicators to assess Marker Therapeutics Inc. potential2025 Stock Rankings & Weekly Setup with ROI Potential - Newser
What earnings revisions data tells us about Marker Therapeutics Inc.Earnings Risk Summary & Expert Curated Trade Ideas - Newser
Can trapped investors hope for a rebound in Marker Therapeutics Inc.Quarterly Portfolio Report & Consistent Growth Equity Picks - Newser
Applying chart zones and confluence areas to Marker Therapeutics Inc.Weekly Trade Recap & Daily Profit Maximizing Trade Tips - Newser
Marker Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference - AInvest
Marker Therapeutics Inc. Enters Reversal Setup in Weekly Charts2025 Buyback Activity & Entry and Exit Point Strategies - beatles.ru
Marker Therapeutics Inc. Stock Lags Behind Sector BenchmarksQuarterly Trade Report & Free Fast Entry Momentum Trade Alerts - 선데이타임즈
Finanzdaten der Marker Therapeutics Inc-Aktie (MRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):